Correlation Between Effector Therapeutics and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Cidara Therapeutics, you can compare the effects of market volatilities on Effector Therapeutics and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Cidara Therapeutics.
Diversification Opportunities for Effector Therapeutics and Cidara Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Effector and Cidara is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Cidara Therapeutics
Given the investment horizon of 90 days Effector Therapeutics is expected to generate 1.84 times less return on investment than Cidara Therapeutics. But when comparing it to its historical volatility, Effector Therapeutics is 1.38 times less risky than Cidara Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Cidara Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1,028 in Cidara Therapeutics on February 21, 2024 and sell it today you would earn a total of 98.00 from holding Cidara Therapeutics or generate 9.53% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Effector Therapeutics vs. Cidara Therapeutics
Performance |
Timeline |
Effector Therapeutics |
Cidara Therapeutics |
Effector Therapeutics and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Effector Therapeutics and Cidara Therapeutics
The main advantage of trading using opposite Effector Therapeutics and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Cidara Therapeutics vs. CytomX Therapeutics | Cidara Therapeutics vs. Clearside Biomedical | Cidara Therapeutics vs. GlycoMimetics | Cidara Therapeutics vs. TRACON Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |